Shares of Sareum Holdings Plc (LON: SAR) surged 24% after the company announced that it had received US patent protection for its pre-clinical cancer programme.
The biotech company received US patent protection over its SDC-1802 TYK2/JAK1 kinase inhibitor programme, a pre-clinical treatment that targets cancer.
Today’s patent approval is the last step for the company given that it has already received patents from Europe, Japan and China.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Dr John Reader, the chief scientific officer for the programme, said: “The granting of this patent in the US completes the protection of the intellectual property for our proprietary SDC-1802 Programme across all major markets.”
Adding:
“The board believes that the patent will enhance the value of its TYK2/JAK1 inhibitor programmes and the company’s negotiating position as it continues to engage in discussions with potential licence partners.”
Today’s announcement led Sareum shares to break above the crucial 2.60p resistance level before quickly falling back below the level.
The stock could set up for a rally if the price follows through and rises above the level, or could head into a downtrend if the level holds over the next few days.
Sareum share price
Sareum shares surged 24% to trade at 2.73p having rallied from Wednesday’s closing price of 2.20p.
